Low-dose Trifluridine/Tipiracil With Bevacizumab in mCRC

Clinical trial NCT07085169 · RECRUITING

Trial details

NCT number: NCT07085169
Sponsor: Ruijin Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Colo-rectal Cancer Third-line and Beyond Therapy TAS 102 Bevacizumab

Start date: 2025-08-01
Primary completion: 2027-08-01
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.